Renal cell carcinoma treatment

Renal cell carcinoma, the most common form of kidney cancer in adults, frequently spreads to the lungs, making its intersection with pulmonary medicine a critical area of clinical concern. Researchers are working to understand how molecular and genetic characteristics of tumors predict disease course, guide decisions about nephron-sparing surgery, and determine which patients are most likely to respond to immunotherapy or targeted agents. Despite meaningful progress in systemic treatments, durable responses in metastatic disease remain difficult to achieve, and identifying reliable biomarkers that distinguish responders from non-responders is an active and unresolved challenge. Work is also ongoing to refine clinical guidelines that integrate new molecular data with established prognostic factors, aiming to move treatment decisions closer to true personalization.

Works

90,791

Total citations

1,167,609

Keywords

Renal Cell CarcinomaMetastaticTreatmentTherapyPrognostic FactorsMolecular Characterization